Clinical Trials in Detroit

Showing 12881-12900 of 19,719 trials

Immunogenicity of PCV-7 Vaccine in VLBW Infants

NCT00273325

Premature infants are at a high risk for pneumonia. The PCV-7 vaccine effectively prevents the invasive disease from Streptococcus pneumoniae in full-term infants, but was not thoroughly studied in premature infants. This study evaluated the effectiveness and safety of the vaccine given in routine practice to very low birth weight infants, looking at blood antibody levels 4-6 weeks after the final vaccine dose, and adverse events, survival, infections, and neurodevelopmental outcomes at 18-22 months corrected age.

Pneumococcal InfectionsStreptococcus PneumoniaeInfant, Newborn+3 more

NICHD Neonatal Research Network368 participantsStarted Jul 2004

Birmingham, Alabama, United States • Palo Alto, California, United States • Miami, Florida, United States +7 more locations

COMPLETED< 1 mile

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

NCT01203423

This study was an observational study to estimate the prevalence of Persistent pulmonary hypertension of the newborn (PPHN) among term or near-term infants with severe respiratory disease.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+3 more

NICHD Neonatal Research Network385 participantsStarted Oct 1993

Palo Alto, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +10 more locations

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Find Trials by Condition in Detroit

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Early Diagnosis of Candidiasis in Premature Infants

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

Whole-Body Cooling for Birth Asphyxia in Term Infants

Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)

Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents

Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination

DF4 Connector System Post-Approval Study

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

A Study of LY3113593 in Participants With Chronic Kidney Disease

Use of the VisuMax™ Femtosecond Laser

A Brief Educational Intervention to Improve Traumatic Brain Injury (TBI) Screening Outcomes

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia